Of note, however, is that the removal of LSD1 in melanoma induced the expression of TGF-β, which suppresses T-cell immunity; as a result, the tumor could not be completely eradicated despite the enhanced efficacy of the combination with ICIs144,147. The gene discussed is KDM1A; the disease is melanoma.